Hiroshi Ito

Active 1916–2026

Also published as
Hiroshi Itô
570
Papers
55,857
Citations
126
h-index
413
i10-index

Citations

Citations per year for Hiroshi Ito1947: 1 citations1958: 1 citations1965: 1 citations1970: 1 citations1971: 1 citations1972: 5 citations1973: 3 citations1974: 4 citations1975: 2 citations1976: 3 citations1977: 2 citations1978: 4 citations1979: 1 citations1980: 2 citations1981: 3 citations1982: 3 citations1983: 1 citations1984: 5 citations1985: 4 citations1986: 5 citations1987: 4 citations1988: 4 citations1989: 9 citations1990: 3 citations1991: 10 citations1992: 11 citations1993: 10 citations1994: 30 citations1995: 66 citations1996: 88 citations1997: 95 citations1998: 125 citations1999: 123 citations2000: 201 citations2001: 215 citations2002: 220 citations2003: 229 citations2004: 241 citations2005: 249 citations2006: 273 citations2007: 327 citations2008: 422 citations2009: 433 citations2010: 440 citations2011: 452 citations2012: 484 citations2013: 424 citations2014: 458 citations2015: 465 citations2016: 431 citations2017: 422 citations2018: 348 citations2019: 1,099 citations2020: 1,181 citations2021: 1,126 citations2022: 867 citations2023: 690 citations2024: 1,626 citations2025: 1,134 citations2026: 85 citations1948–1957: no citations, so these years are not shown1959–1964: no citations, so these years are not shown1966–1969: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,108 citing papers, 25.7% of this breakdownJapan: 2,192 citing papers, 11% of this breakdownChina: 1,586 citing papers, 8% of this breakdownUnited Kingdom: 1,378 citing papers, 6.9% of this breakdownGermany: 1,157 citing papers, 5.8% of this breakdownItaly: 868 citing papers, 4.4% of this breakdownCanada: 818 citing papers, 4.1% of this breakdownFrance: 633 citing papers, 3.2% of this breakdownNetherlands: 502 citing papers, 2.5% of this breakdownAustralia: 456 citing papers, 2.3% of this breakdownSpain: 376 citing papers, 1.9% of this breakdownSwitzerland: 345 citing papers, 1.8% of this breakdown
0%25.7%Other 22.4%

Fields

  • Medicine57.6%
  • Neuroscience14.9%
  • Biochemistry, Genetics and Molecular Biology11.2%
  • Engineering7.7%
  • Immunology and Microbiology2.4%
  • Computer Science1.5%
  • Other4.7%

Topics

  • Neuroscience and Neuropharmacology Research2.4%
  • Cardiovascular Function and Risk Factors2.2%
  • Cardiac Imaging and Diagnostics2.1%
  • Diabetes Treatment and Management1.6%
  • Heart Failure Treatment and Management1.4%
  • Coronary Interventions and Diagnostics1.4%
  • Other88.9%

Coauthors

All papers

Open in search
  1. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark C. Petrie - New England Journal of Medicine 2023 cited by 1,436

  2. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis Wolf, Sanjiv J. Shah - New England Journal of Medicine 2024 cited by 632

  3. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis Wolf, Mikhail Kosiborod - The Lancet 2024 cited by 323

  4. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 188

  5. Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 1,461

  6. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus

    Authors: , , , , , , , , , , , , , - International Journal of Molecular Sciences 2022 cited by 252

  7. JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tsutomu Yoshikawa, Michihiro Yoshimura, Masatoshi Akiyama, Toshihisa Anzai, Shiro Ishihara, Takayuki Inomata, Teruhiko Imamura, Yu‐ki Iwasaki, Tomohito Ohtani, Katsuya Onishi, Takatoshi Kasai, Mahoto Kato, Makoto Kawai, Yoshiharu Kinugasa, Shintaro Kinugawa, Toru Kuratani, Shigeki Kobayashi, Yasuhiko Sakata, Atsushi Tanaka, Köichi Toda, Takashi Noda, Kotaro Nochioka, Masaru Hatano, Takayuki Hidaka, Takeo Fujino, Shigeru Makita, Osamu Yamaguchi, Uichi Ikeda, Takeshi Kimura, Shun Kohsaka, Masami Kosuge, Masakazu Yamagishi, Akira Yamashina, on behalf of the Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group - Circulation Journal 2019 cited by 704

  8. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2007 cited by 1,985

  9. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial

    Authors: , , , , , , , , , , , , , , - Circulation 2023 cited by 92

  10. Efficient multitask learning with an embodied predictive model for door opening and entry with whole-body control

    Authors: , , , - Science Robotics, Sci. Robotics 2022 cited by 82

  11. Semaglutide and NT-proBNP in Obesity-Related HFpEF

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2024 cited by 82

  12. JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Journal 2021 cited by 180

  13. Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2024 cited by 116

  14. Generation of influenza A viruses entirely from cloned cDNAs

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 1,316

  15. Reconstitution of Circadian Oscillation of Cyanobacterial KaiC Phosphorylation in Vitro

    Authors: , , , , , , , - Science 2005 cited by 1,123

  16. Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 cited by 81

  17. A prefrontal–thalamo–hippocampal circuit for goal-directed spatial navigation

    Authors: , , , , - Nature 2015 cited by 503

  18. JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Cardiac Failure 2021 cited by 158

  19. Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Neuron 2013 cited by 772

  20. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , - Circulation Cardiovascular Quality and Outcomes 2017 cited by 335

  21. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nobuhiro Tanabe, Ichizo Tsujino, Atsushi Yao, Takashi Akasaka, Motomi Ando, Takeshi Kimura, Takayuki Kuriyama, Norifumi Nakanishi, Toshio Nakanishi, Hiroyuki Tsutsui, on behalf of the Japanese Circulation Society and the Japanese Pulmonary Circulation and Pulmonary Hypertension Society Joint Working Group - Circulation Journal 2019 cited by 222

  22. The orbitofrontal cortex maps future navigational goals

    Authors: , , , , , , - Nature 2021 cited by 110

  23. Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension

    Authors: , , , , , - Circulation Cardiovascular Interventions 2012 cited by 601

  24. Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage

    Authors: , , , , - Aging Cell 2007 cited by 221